Giovan Battista Ruffo

New film‐coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower‐risk MDS: Results of the randomized, phase II ECLIPSE study

Alì Taher, Raffaella Origa, Silverio Perrotta et al. · American Journal of Hematology · 2017 · 77 citations · Full text

Pharmaceutical Science, Tablet Formulation, Pharmacotherapy +23

Myocardial iron overload in thalassaemia major. How early to check?

Caterina Borgna‐Pignatti, Antonella Meloni, Giulia Guerrini et al. · British Journal of Haematology · 2014 · 56 citations · Full text

Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C

V. Di Marco, Marcello Capra, Francesco Gagliardotto et al. · Haematologica · 2008 · 52 citations · Full text

Liver Iron Concentration, Chelated Transfusion-dependent Thalassemics, Pathology +22

Improvement of heart iron with preserved patterns of iron store by CMR-guided chelation therapy

Antonella Meloni, Vincenzo Positano, Giovan Battista Ruffo et al. · European Heart Journal - Cardiovascular Imaging · 2014 · 46 citations · Full text

Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias

Alì Taher, Raffaella Origa, Silverio Perrotta et al. · Health and Quality of Life Outcomes · 2018 · 24 citations · Full text